Article
October 7, 2026
Three critical water risks pharma sites need to consider
For pharmaceutical manufacturers, water challenges extend far beyond whether enough water is available. The industry's dependence on high-quality water, increasing scrutiny of wastewater discharges, and growing attention on pharmaceuticals in the aquatic environment are reshaping how companies evaluate sites, design facilities, and manage operations.
Contact our expert
Elyse Smith
Senior Project Manager
As production networks expand and the lifetime of pharmaceutical facilities lengthens, water-related risks can directly affect regulatory compliance, operational resilience, capital investment decisions, and sustainability commitments. Forward-looking organisations recognise that effective water stewardship starts with understanding three interconnected challenges: securing high-quality source water, managing complex wastewater streams, and addressing emerging regulations and public perception related to pharmaceutical residues in the environment.
Reliable, high-quality water is essential to operations
Water is one of the most essential raw materials in pharmaceutical manufacturing as it is needed throughout production processes, utility systems, cleaning operations, laboratories, and cooling systems. However, producing purified water requires sophisticated treatment systems capable of consistently meeting stringent quality standards. Variations in source water chemistry, seasonal fluctuations, emerging contaminants, and changes in watershed conditions can all affect treatment requirements and operating costs.
Understanding these risks early can help organisations design more resilient water systems, identify alternative supply strategies, and ensure long-term reliability for critical manufacturing operations.
Senior Project Manager
Wastewater management is becoming more complex
Pharmaceutical wastewater can contain elevated organic loadings, process chemicals, solvents, nutrients, cleaning compounds, and other constituents that require specialised treatment approaches. As regulations and public expectations evolve, facilities are expected to demonstrate effective management of these complex wastewater streams. Many organisations are taking a broader approach to wastewater management that considers operational efficiency, water reuse opportunities, treatment resilience, and future regulatory requirements.
This shift can be attributed to several emerging trends, including regulators paying closer attention to industrial discharges, communities focusing on protecting local water resources, and investors and stakeholders requiring stronger environmental performance metrics. At the same time, many facilities are seeking to reduce freshwater consumption through recycling and reuse initiatives, which often require more sophisticated treatment technologies.
Addressing pharmaceuticals in the aquatic environment
While the topic of pharmaceuticals in our environment encompasses a range of environmental and public health considerations, it has become a critical component of corporate sustainability strategies and responsible manufacturing practices. Organisations are conducting more comprehensive evaluations of environmental risk, including assessing manufacturing processes, evaluating treatment system performance, understanding receiving water sensitivities, and considering advanced treatment technologies where appropriate.
But the issue often extends beyond individual facilities with stakeholders increasingly expecting companies to demonstrate a proactive approach to managing environmental impacts throughout the product lifecycle. As a result, pharmaceutical manufacturers are incorporating considerations related to aquatic environmental protection into facility planning, operational decision-making, and water stewardship programmes.
Key takeaways
Turning water stewardship into action
With these considerations in mind, pharmaceutical companies can strengthen water stewardship by taking a few proactive and practical actions that embed the practice into site planning, facility design, operations, and long-term business strategy.
1
Identify and map water use and risk across manufacturing processes, utilities, and sites to identify critical dependencies, inefficiencies, source-water vulnerabilities, and water reduction opportunities.
2
Set site-specific targets and/or best practices for water efficiency, reuse, discharge quality, and resilience, supported by clear accountability, performance metrics, and regular reviews.
3
Build resilience into treatment systems and operational plans by preparing for changing source-water conditions, emerging contaminants, regulatory requirements, and disruptions, while engaging key stakeholders early.
A strategic imperative
As companies invest in the next generation of manufacturing facilities, water stewardship is becoming less about managing a utility and more about protecting a critical business resource. Organisations that address these considerations early will be better positioned to support reliable production, navigate evolving regulations, and build resilience in a water-conscious future.
Explore more within Life Sciences and Pharma
Discover how Ramboll helps pharma and biopharma organisations develop advanced manufacturing sites that enhance market readiness and shorten time‑to‑market for new therapies.
Contact our expert
Senior Project Manager
